The following articles about the QAAMS Program have been published in peer reviewed national and international journals
Results from 16 years of quality surveillance of urine albumin to creatinine ratio testing for a National Indigenous Point-of-Care Testing Program
Archives of Pathology and Laboratory Medicine, 2020
Regnier T, Shephard M, Shephard A, Graham P, DeLeon, R, Shephard S
Results from 15 years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes.
Clinical Biochemistry, 2017
Shephard M, Shepherd A, McAteer B, Regnier T, Barancek K
Review of the cultural safety of a national Indigenous Point-of-Care testing program for diabetes management.
Australian Journal of Primary Health, 2015
Shephard M, O’Brien C, Burgoyne A, Croft J, Garlett T, Barancek K, Halls H, McAteer B, Motta L, Shephard A
Point-of-Care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care.
Rural and Remote Health, 2014
Spaeth BA, Shephard MDS, Schatz S
The Status, Practical Advantages, and Benefits of Community Resiliency
Point of Care, 2013
Jones GR, Barker G, Goodall I, Schneider HG, Shephard MDS, Twigg SM. Change of HbA1c reporting to the new SI units. Medical Journal of Australia 2011; 195 (1): 45-46. Access
Shephard MDS and Gill J. The national QAAMS Program – A practical example of PoCT working in the community. Clinical Biochemist Reviews 2010; 31: 95-99. Access
Shephard MDS and Gill JP. The analytical quality of point-of-care testing in the ‘QAAMS’ model for diabetes management in Australian Aboriginal medical services. Clinical Biochemist Reviews 2006; 27: 185-190. Access
Shephard M. Clinical and cultural effectiveness of the ‘QAAMS’ point-of-care testing model for diabetes management in Australian Aboriginal medical services. Clinical Biochemist Reviews 2006; 27: 161-170. Access
Shephard MDS and Gill JP. An innovative Australian point-of-care model for urine albumin:creatinine ratio testing that supports diabetes management in indigenous medical services and has international application. Annals of Clinical Biochemistry 2005; 42: 208-215. Access
Shephard MDS and Gill J. Results of an Innovative Education, Training and Quality Assurance Program for Point-of-Care HbA1c Testing using the Bayer DCA 2000 in Australian Aboriginal Community Controlled Health Services. Clinical Biochemist Reviews 2003; 24: 123-131. Access
Shephard MDS and Mundraby K. Assisting Diabetes Management Through Point-of-Care HbA1c Testing - The 'QAAMS' Program for Aboriginal Health Workers. Aboriginal and Islander Health Worker Journal 2003; 27: 4: 12-18. Access